Search results
Showing 616 to 630 of 9040 results
All NICE products on heavy menstrual bleeding. Includes any guidance and quality standards.
All NICE products on workplaces. Includes any guidance and quality standards.
This quality standard covers assessing and treating fertility problems in people with explained and unexplained infertility, including access to IVF treatment. It also covers cryopreservation before cancer treatment that may affect fertility. It describes high-quality care in priority areas for improvement.
View quality statements for QS73Show all sections
Sections for QS73
- List of quality statements
- Quality statement 1: Lifestyle advice
- Quality statement 2: Referral for specialist consultation
- Quality statement 3: Counselling
- Quality statement 4: Semen analysis
- Quality statement 5: IVF for women, trans men and non-binary people with female reproductive organs aged under 40 years
- Quality statement 6: IVF for women, trans men and non-binary people with female reproductive organs aged 40 or 41 years
- Quality statement 7: Intracytoplasmic sperm injection
This quality standard covers diagnosing, managing and treating rare diseases in children, young people and adults. It describes high-quality care in priority areas for improvement.
View quality statements for QS214Show all sections
Sections for QS214
- Quality statements
- Quality statement 1: Referral for investigation and treatment
- Quality statement 2: Undiagnosed conditions
- Quality statement 3: Information provision
- Quality statement 4: Shared decision making
- Quality statement 5: Named healthcare professional
- Quality statement 6: Holistic needs assessment
- Quality statement 7: Access to treatment
All NICE products on breast cancer. Includes any guidance, advice and quality standards.
This webpage covers all NICE's guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within...
All NICE products on postnatal care. Includes any guidance and quality standards.
All NICE products on suicide prevention. Includes any guidance and quality standards.
All NICE products on urinary tract infection. Includes any guidance, advice and quality standards.
All NICE products on parkinson's disease, tremor and dystonia. Includes any guidance, advice and quality standards.
All NICE products on mesothelioma. Includes any guidance.
All NICE products on endometrial cancers. Includes any guidance.
All NICE products on cervical cancer. Includes any guidance.
All NICE products on liver cancers. Includes any guidance.
This quality standard covers the identification and management of familial and genetic risk and the recognition and management of ovarian, fallopian tube and primary peritoneal cancer or borderline ovarian cancer in women, trans men and non-binary people aged 18 and over with female reproductive organs (ovaries, fallopian tubes or a uterus). It describes high-quality care in priority areas for improvement.
View quality statements for QS18Show all sections
Sections for QS18
- Quality statements
- Quality statement 1: Discussion about risk-reducing surgery
- Quality statement 2: CA125 blood test – age-specific thresholds
- Quality statement 3: Panel germline genetic testing for non-mucinous high-grade epithelial ovarian cancer
- Quality statement 4: Tumour genetic testing for stage 3 or 4 non-mucinous high-grade epithelial ovarian cancer
- Quality statement 5: Treatment of high-risk stage 1 or stage 2 to 4 ovarian cancer
- Update information
- About this quality standard